Annexon Biosciences takes in $75 mln Series C

South San Francisco-based Annexon Biosciences, a biopharmaceutical company, has raised $75 million in Series C financing. Bain Capital Life Sciences led the round with participation from Surveyor Capital, Adage Capital Partners, New Enterprise Associates, Blackstone Life Sciences, Novartis Venture Fund and Satter Investment Management.

ManagersNorth AmericaUSHealthcareBriefs